These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19852697)

  • 21. Effects of the Medicare Alzheimer's Disease Demonstration on caregiver burden and depression.
    Newcomer R; Yordi C; DuNah R; Fox P; Wilkinson A
    Health Serv Res; 1999 Aug; 34(3):669-89. PubMed ID: 10445897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect on caregiver burden of a problem-based home visiting programme for frail older people.
    Melis RJ; van Eijken MI; van Achterberg T; Teerenstra S; Vernooij-Dassen MJ; van de Lisdonk EH; Rikkert MG
    Age Ageing; 2009 Sep; 38(5):542-7. PubMed ID: 19574322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.
    Freund-Levi Y; Basun H; Cederholm T; Faxén-Irving G; Garlind A; Grut M; Vedin I; Palmblad J; Wahlund LO; Eriksdotter-Jönhagen M
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):161-9. PubMed ID: 17582225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Validity and reliability of the Japanese version of the Neuropsychiatric Inventory Caregiver Distress Scale (NPI D) and the Neuropsychiatric Inventory Brief Questionnaire Form (NPI-Q)].
    Matsumoto N; Ikeda M; Fukuhara R; Hyodo T; Ishikawa T; Mori T; Toyota Y; Matsumoto T; Adachi H; Shinagawa S; Hokoishi K; Tanabe H; Hirono N
    No To Shinkei; 2006 Sep; 58(9):785-90. PubMed ID: 17052006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caregiver characteristics are associated with neuropsychiatric symptoms of dementia.
    Sink KM; Covinsky KE; Barnes DE; Newcomer RJ; Yaffe K
    J Am Geriatr Soc; 2006 May; 54(5):796-803. PubMed ID: 16696746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of switching from an AChE inhibitor to a dual AChE-BuChE inhibitor in patients with Alzheimer's disease.
    Bartorelli L; Giraldi C; Saccardo M; Cammarata S; Bottini G; Fasanaro AM; Trequattrini A;
    Curr Med Res Opin; 2005 Nov; 21(11):1809-18. PubMed ID: 16307702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics.
    Jones RW; Kivipelto M; Feldman H; Sparks L; Doody R; Waters DD; Hey-Hadavi J; Breazna A; Schindler RJ; Ramos H;
    Alzheimers Dement; 2008 Mar; 4(2):145-53. PubMed ID: 18631958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive, functional and behavioral factors associated with the burden of caring for geriatric patients with cognitive impairment or depression: evidence from a South American sample.
    Machnicki G; Allegri RF; Dillon C; Serrano CM; Taragano FE
    Int J Geriatr Psychiatry; 2009 Apr; 24(4):382-9. PubMed ID: 18836985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do patients diagnosed with Alzheimer's disease benefit from a psycho-educational programme for family caregivers? A randomised controlled study.
    de Rotrou J; Cantegreil I; Faucounau V; Wenisch E; Chausson C; Jegou D; Grabar S; Rigaud AS
    Int J Geriatr Psychiatry; 2011 Aug; 26(8):833-42. PubMed ID: 20922772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-efficacy for managing dementia may protect against burden and depression in Alzheimer's caregivers.
    Gallagher D; Ni Mhaolain A; Crosby L; Ryan D; Lacey L; Coen RF; Walsh C; Coakley D; Walsh JB; Cunningham C; Lawlor BA
    Aging Ment Health; 2011 Aug; 15(6):663-70. PubMed ID: 21547745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative importance of patient disease indicators on informal care and caregiver burden in Alzheimer's disease.
    Bergvall N; Brinck P; Eek D; Gustavsson A; Wimo A; Winblad B; Jönsson L
    Int Psychogeriatr; 2011 Feb; 23(1):73-85. PubMed ID: 20619068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does cognitive impairment influence burden in caregivers of patients with Alzheimer's disease?
    Germain S; Adam S; Olivier C; Cash H; Ousset PJ; Andrieu S; Vellas B; Meulemans T; Reynish E; Salmon E;
    J Alzheimers Dis; 2009; 17(1):105-14. PubMed ID: 19494435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychiatric Symptoms, Caregiver Burden and Distress in Behavioral-Variant Frontotemporal Dementia and Alzheimer's Disease.
    Lima-Silva TB; Bahia VS; Carvalho VA; Guimarães HC; Caramelli P; Balthazar ML; Damasceno B; Bottino CM; Brucki SM; Nitrini R; Yassuda MS
    Dement Geriatr Cogn Disord; 2015; 40(5-6):268-75. PubMed ID: 26302667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERAS.
    Reed C; Belger M; Scott Andrews J; Tockhorn-Heidenreich A; Jones RW; Wimo A; Dodel R; Haro JM
    Int Psychogeriatr; 2020 Feb; 32(2):267-277. PubMed ID: 31134870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive factors of emergency hospitalisation in Alzheimer's patients: results of one-year follow-up in the REAL.FR Cohort.
    Balardy L; Voisin T; Cantet C; Vellas B;
    J Nutr Health Aging; 2005; 9(2):112-6. PubMed ID: 15791355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of potential measures in models of progression in Alzheimer disease.
    McLaughlin T; Buxton M; Mittendorf T; Redekop W; Mucha L; Darba J; Jonsson L; Lacey L; Leibman C
    Neurology; 2010 Oct; 75(14):1256-62. PubMed ID: 20921511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional dependence and caregiver burden in Alzheimer's disease: a controlled trial on the benefits of motor intervention.
    Canonici AP; Andrade LP; Gobbi S; Santos-Galduroz RF; Gobbi LT; Stella F
    Psychogeriatrics; 2012 Sep; 12(3):186-92. PubMed ID: 22994617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences between physician and caregiver evaluations in Alzheimer's disease.
    Sinforiani E; Pasotti C; Chiapella L; Malinverni P; Zucchella C
    Funct Neurol; 2010; 25(4):205-9. PubMed ID: 21388581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.